Filing Details

Accession Number:
0000899243-16-026291
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-04 15:30:16
Reporting Period:
2016-08-02
Filing Date:
2016-08-04
Accepted Time:
2016-08-04 15:30:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1105533 Argos Therapeutics Inc ARGS Pharmaceutical Preparations (2834) 562110007
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1598754 Public Joint Stock Co Pharmstandard Likhacevsky Drive 5 &Quot;B&Quot;
Dolgoprudny 1Z 141700
No No Yes No
1598762 S.a. International Pharmstandard 10A, Rue Henri Schnadt
Luxembourg N4 L-2530
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-02 2,363,636 $0.00 12,811,020 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrant to Purchase Common Stock Acquisiton 2016-08-02 1,772,727 $0.00 1,772,727 $5.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,772,727 2016-08-02 2021-08-02 No 4 P Indirect
Footnotes
  1. The reported securities were purchased by the Reporting Person for $5.50 per share of common stock and accompanying warrant. The shares of common stock and warrants were purchased in combination, with one warrant to purchase up to 0.75 of a share of common stock accompanying each share of common stock.
  2. Pharmstandard International S.A. is a wholly owned subsidiary of Public Joint Stock Company Pharmstandard. As the parent entity, Public Joint Stock Company Pharmstandard has voting power over the shares of the Issuer held by Pharmstandard International S.A.